The family of Epidermolysis Bullosa (EB) patient Rafaella Kopelan is working closely with a pharmaceutical company that may soon provide a topical treatment to cure blisters caused by EB. The pharmaceutical company Scioderm is in turn, working closely with FDA to quicken the pace to get the drug approved.
